Promoter methylation was reported to cause RKIP downregulation in many different tumours and tumour cells, e.g., oesophageal squamous cell carcinomas, gastric adenocarcinomas and breast carcinoma cells [86,87,88]. Here, PEBP1 is linked to breast carcinoma.